FDA Logo links to FDA home page   Center for Drug Evaluation and Research, U.S. Food and Drug Administration U.S. Food and Drug Administration Center for Drug Evaluation and Research   HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
Powered by Google
- Stay Informed -
Subscribe to Daily/Weekly Updates

News from CDER

 September 12. Genentech informs healthcare professionals of revisions to prescribing information for Rituxan regarding a case of progressive multifocal leukoencephalopathy (PML). MedWatch Safety Information

 September 5. FDA posts quarterly report of potential safety issues. FDA News

 September 4. FDA announces that manufacturers of TNF-blocker drugs (Cimzia, Enbrel, Humira, and Remicade) must highlight the risk of fungal and serious opportunistic infections. FDA News

 August 25. FDA updates the Information for Healthcare Professionals sheet for Tysabri (natalizumab). Drug Information

Previous News Items

Drug Safety: About FDA's New Drug Safety Initiative

About FDA's
Drug Safety Initiative

Safety Information for Specific Drugs
Consumer Education Helping you make informed decisions about using medicines.
FDA Drug Safety Podcasts
FDA Drug Safety Newsletter

Featured Links

  What You Should Know
about Prescription Drug Advertisements
  CDER 2007 Update: Improving Public Health Through Human Drugs.
  Facts@FDA Download available Structured Product Labeling

Stop -- Learn -- Go -- to www.fda.gov/usemedicinesafely


Main FDA number: 1-888-INFO-FDA (1-888-463-6332)
Drug Information Number: 301-796-3400  (8:00 am - 4:30 pm Eastern Time)


Page Last Updated: September 12, 2008

MedlinePlus: Trusted Health Information for You

Link to USA.gov, The U.S. government's Official Web Portal

horizonal rule